The present invention refers to humanized anti Trop 2 antibodies and their fragments derivatives and conjugates that are able to recognise and bind with high affinity distinct regions of the Trop 2 molecule. The present invention also teaches the use of such antibodies and of pharmaceutical compositions thereof for diagnosis and therapy of human pathologies in particular cancer.